Femoston Low 0,5 mg - 2,5 mg Film-coated tablet 벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

femoston low 0,5 mg - 2,5 mg film-coated tablet

impexeco - estradiol hemihydrate; dydrogesterone - film-coated tablet - 0,5 mg - 2,5 mg - estradiol hemihydrate 0.517 mg; dydrogesterone 2.5 mg - dydrogesterone and estrogen

Femoston Low 0,5 mg - 2,5 mg Film-coated tablet 벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

femoston low 0,5 mg - 2,5 mg film-coated tablet

orifarm - dydrogesterone; estradiol hemihydrate - film-coated tablet - 0,5 mg - 2,5 mg - dydrogesterone 2.5 mg; estradiol hemihydrate - dydrogesterone and estrogen

Femoston-conti 0.5mg/2.5mg tablets 영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

femoston-conti 0.5mg/2.5mg tablets

viatris uk healthcare ltd - estradiol; dydrogesterone - oral tablet - 500microgram ; 2.5mg

Femoston 2/10 뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

femoston 2/10

viatris limited - estradiol 2mg; dydrogesterone 10mg; estradiol 2mg - tablet - active: estradiol 2mg excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate maize starch opadry orange oy-23000 active: dydrogesterone 10mg estradiol 2mg excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate maize starch opadry yellow oy-7915 - hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uterus. for initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration should be used with the goal being short term use.